These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 33950697)

  • 21. Modeling Lewy pathology propagation in Parkinson's disease.
    Luk KC; Lee VM
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S85-7. PubMed ID: 24262196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.
    Braak H; Sastre M; Del Tredici K
    Acta Neuropathol; 2007 Sep; 114(3):231-41. PubMed ID: 17576580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells.
    Gao J; Perera G; Bhadbhade M; Halliday GM; Dzamko N
    J Biol Chem; 2019 Sep; 294(39):14241-14256. PubMed ID: 31375560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
    Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity?
    Chartier S; Duyckaerts C
    Cell Tissue Res; 2018 Jul; 373(1):149-160. PubMed ID: 29869713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
    Eyal A; Engelender S
    Cell Cycle; 2006 Sep; 5(18):2082-6. PubMed ID: 16969096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons.
    Volpicelli-Daley LA; Abdelmotilib H; Liu Z; Stoyka L; Daher JP; Milnerwood AJ; Unni VK; Hirst WD; Yue Z; Zhao HT; Fraser K; Kennedy RE; West AB
    J Neurosci; 2016 Jul; 36(28):7415-27. PubMed ID: 27413152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functionally different α-synuclein inclusions yield insight into Parkinson's disease pathology.
    Raiss CC; Braun TS; Konings IB; Grabmayr H; Hassink GC; Sidhu A; le Feber J; Bausch AR; Jansen C; Subramaniam V; Claessens MM
    Sci Rep; 2016 Mar; 6():23116. PubMed ID: 26984067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting alpha-synuclein for the treatment of Parkinson's disease.
    Rohn TT
    CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):174-9. PubMed ID: 22483285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.
    Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ
    Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
    Norris EH; Giasson BI
    Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lewy bodies in Parkinson's disease: histological, immunohistochemical, and interferometric examinations].
    Voronkov DN; Salkov VN; Anufriev PL; Khudoerkov RM
    Arkh Patol; 2018; 80(4):9-13. PubMed ID: 30059066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational templating of α-synuclein aggregates in neuronal-glial cultures.
    Sacino AN; Thomas MA; Ceballos-Diaz C; Cruz PE; Rosario AM; Lewis J; Giasson BI; Golde TE
    Mol Neurodegener; 2013 May; 8():17. PubMed ID: 23714769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-synuclein, lipids and Parkinson's disease.
    Ruipérez V; Darios F; Davletov B
    Prog Lipid Res; 2010 Oct; 49(4):420-8. PubMed ID: 20580911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.
    Hayakawa H; Nakatani R; Ikenaka K; Aguirre C; Choong CJ; Tsuda H; Nagano S; Koike M; Ikeuchi T; Hasegawa M; Papa SM; Nagai Y; Mochizuki H; Baba K
    Mov Disord; 2020 Feb; 35(2):256-267. PubMed ID: 31643109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.
    Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U
    Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ; Kawamata H; Hyman BT
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.
    Wang R; Sun H; Ren H; Wang G
    Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.